                               SEQUENCE LISTING                               

<110> Medarex, Inc.
      Sufi, Bilal
      Guerlavais, Vincent
      Chen, Liang
      Gangwar, Sanjeev
      Zhang, Qian
      Passmore, David B.

<120> CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND 
      CONJUGATES THEREOF

<130> 2203238-WO0

<150> 60/991,300
<151> 2007-11-30

<150> 60/882,461
<151> 2006-12-28

<160> 15                            

<170> PatentIn Ver. 3.3

<210> 1
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 1
Ala Leu Ala Leu                                                  
  1            


<210> 2
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<220> 
<221> MOD_RES
<222> (1)
<223> Beta-Ala

<400> 2
Ala Leu Ala Leu                                                  
  1            


<210> 3
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 3
Gly Phe Leu Gly                                                  
  1            


<210> 4
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 4
Pro Arg Phe Lys                                                  
  1            


<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 5
Thr Arg Leu Arg                                                  
  1            


<210> 6
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 6
Ser Lys Gly Arg                                                  
  1            


<210> 7
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 7
Pro Asn Asp Lys                                                  
  1            


<210> 8
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 8
Pro Val Gly Leu Ile Gly                                          
  1               5    


<210> 9
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 9
Gly Pro Leu Gly Val                                              
  1               5


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 10
Gly Pro Leu Gly Ile Ala Gly Gln                                  
  1               5            


<210> 11
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 11
Pro Leu Gly Leu                                                  
  1            


<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 12
Gly Pro Leu Gly Met Leu Ser Gln                                  
  1               5            


<210> 13
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 13
Gly Pro Leu Gly Leu Trp Ala Gln                                  
  1               5            


<210> 14
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 14
Leu Leu Gly Leu                                                  
  1            


<210> 15
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      Peptide

<400> 15
Pro Leu Gly Leu Leu                                              
  1               5


